Related Experiment Video
Updated: Feb 19, 2026

Dual Effects of Melanoma Cell-derived Factors on Bone Marrow Adipocytes Differentiation
Published on: August 23, 2018
Elucidating the role of adipose tissue secreted factors in malignant transformation
Debrup Chakraborty1, Vanessa Benham1, Jamie J Bernard1
1a Department of Pharmacology and Toxicology , Michigan State University , East Lansing , MI , USA.
Abstract:
Although there is a growing number of incidences of obesity and obesity-linked cancers, how excess adiposity actually causes cancer has not been fully explained. Our previous study showed that removal of visceral adipose tissue significantly reduced the number of ultraviolet radiation (UVR)-initiated, high-fat diet-promoted skin cancers. This commentary focuses on our recently published study (Chakraborty, et al., 2017) which demonstrated that fibroblast growth factor-2 (FGF2) released from visceral adipose tissue is a key factor in the malignant transformation of epithelial cells. Within this commentary we have provided additional interpretations and new data in support of the role of FGF2 in adiposity-associated tumorigenesis.
Insights
Excess body fat, specifically visceral adipose tissue, promotes skin cancer development. Fibroblast growth factor-2 (FGF2) released by this fat is a key driver in the malignant transformation of cells, linking obesity to cancer.
Area of Science:
- Oncology
- Metabolic Syndrome
- Cell Biology
Background:
- Rising incidence of obesity and obesity-linked cancers necessitates understanding the underlying mechanisms.
- Excess adiposity's role in cancer development is not fully elucidated.
- Previous research indicated visceral adipose tissue removal reduced UVR-initiated, high-fat diet-promoted skin cancers.
Purpose of the Study:
- To highlight the role of fibroblast growth factor-2 (FGF2) in adiposity-associated tumorigenesis.
- To provide additional interpretations and data supporting FGF2's function in malignant transformation.
- To explain how excess visceral adipose tissue promotes cancer development.
Main Methods:
- Focuses on a recently published study (Chakraborty, et al., 2017).
- Presents new data and interpretations.
- Examines the effects of fibroblast growth factor-2 (FGF2) released from visceral adipose tissue.
Main Results:
- Fibroblast growth factor-2 (FGF2) released from visceral adipose tissue is a key factor in the malignant transformation of epithelial cells.
- Demonstrates a link between FGF2, visceral adipose tissue, and cancer promotion.
- Supports the role of FGF2 in obesity-associated tumorigenesis.
Conclusions:
- Fibroblast growth factor-2 (FGF2) is a critical mediator linking visceral adipose tissue to cancer development.
- Excess adiposity contributes to tumorigenesis through FGF2 signaling.
- Further research into FGF2 pathways may reveal therapeutic targets for obesity-related cancers.
Related Concept Videos
The Tumor Microenvironment
Abnormal Proliferation
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Mitogens and the Cell Cycle
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

